Amylyx Pharmaceuticals, Inc. (AMLX)
After hours:
| Previous close | 1.7200 |
| Open | 1.7300 |
| Bid | 1.6800 x 800 |
| Ask | 1.7100 x 800 |
| Day's range | 1.6600 - 1.7800 |
| 52-week range | 1.6500 - 26.4400 |
| Volume | |
| Avg. volume | 3,385,119 |
| Market cap | 115.61M |
| Beta (5Y monthly) | -0.68 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
CAMBRIDGE, Mass., May 09, 2024--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today reported financial results for the first quarter ended March 31, 2024.
- Business Wire
Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference
CAMBRIDGE, Mass., May 08, 2024--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced that Joshua Cohen and Justin Klee, Co-CEOs of Amylyx, and Camille L. Bedrosian, MD, Chief Medical Officer of Amylyx, will participate in the 2024 Bank of America Health Care Conference. The conference is being conducted in-person in Las Vegas, Nevada, and the fireside chat will take place on Wednesday, May 15, 2024, at 8:40 a.m. PT/11:40 a.m. ET.
- Business Wire
Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
CAMBRIDGE, Mass., May 02, 2024--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") will report its first quarter 2024 financial results on Thursday, May 9, 2024. Amylyx’ senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and other company updates.
